Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Christmann

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2009
Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavageMaja T Tomicic, Markus Christmann, Bernd Kaina
Cancer Research|October 6, 2005
Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survivalMaja T Tomicic, Markus Christmann, Bernd Kaina
Nucleic Acids Research|April 25, 2002
Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activityMarkus Christmann, Maja T Tomicic, Bernd Kaina
Anticancer Research|February 29, 2024
Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma CellsLea Beltzig, Markus Christmann, Minodora Dobreanu, et al.
Cancers|May 28, 2022
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?Juliana B Vilar, Markus Christmann, Maja T Tomicic
Biomedicines|June 26, 2025
IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to ArtesunateOlivier Switzeny, Stefan Pusch, Markus Christmann, et al.
Biochimica Et Biophysica Acta|July 13, 2011
O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistryMarkus Christmann, Barbara Verbeek, Wynand P Roos, et al.
Archives of Toxicology|June 28, 2018
Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53Christian Steigerwald, Birgit Rasenberger, Markus Christmann, et al.
Biochimica Et Biophysica Acta|May 22, 2012
The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cellsRuth Meise, Maja T Tomicic, Bernd Kaina, et al.
Oncogene|August 17, 2005
Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibitionMarkus Christmann, Maja T Tomicic, Judith Origer, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2009
Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavageMaja T Tomicic, Markus Christmann, Bernd Kaina
Cancer Research|October 6, 2005
Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survivalMaja T Tomicic, Markus Christmann, Bernd Kaina
Nucleic Acids Research|April 25, 2002
Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activityMarkus Christmann, Maja T Tomicic, Bernd Kaina
Anticancer Research|February 29, 2024
Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma CellsLea Beltzig, Markus Christmann, Minodora Dobreanu, et al.
Cancers|May 28, 2022
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?Juliana B Vilar, Markus Christmann, Maja T Tomicic
Biomedicines|June 26, 2025
IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to ArtesunateOlivier Switzeny, Stefan Pusch, Markus Christmann, et al.
Biochimica Et Biophysica Acta|July 13, 2011
O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistryMarkus Christmann, Barbara Verbeek, Wynand P Roos, et al.
Archives of Toxicology|June 28, 2018
Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53Christian Steigerwald, Birgit Rasenberger, Markus Christmann, et al.
Biochimica Et Biophysica Acta|May 22, 2012
The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cellsRuth Meise, Maja T Tomicic, Bernd Kaina, et al.
Oncogene|August 17, 2005
Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibitionMarkus Christmann, Maja T Tomicic, Judith Origer, et al.
Pageof 8